Showing results (701-710 of 711) with videos related to

Sort By:
Pageof 72
Leukemia Research|January 28, 1998
The effects of 13-cis retinoic acid and interferon-alpha in chronic myelogenous leukemia cells in vivo in patientsH Handa, U P Hegde, V M Kotelnikov, et al.
Biological & Pharmaceutical Bulletin|February 1, 1997
In vitro and ex vivo anti-human immunodeficiency virus (HIV) activities of a new water-soluble HIV protease inhibitor, R-87366, containing (2S,3S)-3-amino-2-hydroxy-4-phenylbutanoic acidT Komai, R Yagi, H Suzuki-Sunagawa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1991
Importance of bone marrow cytogenetic evaluation before autologous bone marrow transplantation for Hodgkin's diseaseN J Chao, A P Nademanee, G D Long, et al.
Bioorganic & Medicinal Chemistry|August 1, 1996
Structure-activity relationships of HIV-1 PR inhibitors containing AHPBA--II. Modification of pyrrolidine ring at P1' prolineT Komai, S Higashida, M Sakurai, et al.
Gynecologic Oncology|June 1, 2000
Phase II trial of combination intraperitoneal cisplatin and 5-fluorouracil in previously treated patients with advanced ovarian cancer: long-term follow-upR J Morgan, P Braly, L Leong, et al.
Nature Biotechnology|August 10, 2000
High-performance affinity beads for identifying drug receptorsN Shimizu, K Sugimoto, J Tang, et al.
Leukemia|May 4, 2012
Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomideA Lopez-Girona, D Mendy, T Ito, et al.
Blood Cancer Journal|October 18, 2014
Markedly improved outcomes and acceptable toxicity in adolescents and young adults with acute lymphoblastic leukemia following treatment with a pediatric protocol: a phase II study by the Japan Adult Leukemia Study GroupF Hayakawa, T Sakura, T Yujiri, et al.
Gynecologic Oncology|December 22, 1999
Phase II trial of intraperitoneal cisplatin with intravenous doxorubicin and cyclophosphamide in previously untreated patients with advanced ovarian cancer-long-term follow-upR J Morgan, P Braly, G Cecchi, et al.
European Heart Journal|January 10, 2016
Coping strategies and risk of cardiovascular disease incidence and mortality: the Japan Public Health Center-based prospective StudyThomas Svensson, Manami Inoue, Norie Sawada, et al.
Pageof 72